News About: Pharm. Industry
Government to support Huons’ eye-drop typhoid vaccine project
Huons said Thursday it plans to take part in a government program to develop typhoid vaccine in the form of eye drop, along with Severance Hospital and the Korea Advanced Institute of Science and Technology (KAIST).
...
Cook Medical to expand sales in Korea
Cook Medical Korea, the Korean unit of the U.S.-based Cook Medical Inc., plans to expand its business here.
The company will focus on direct sales and distribution of six Cook products - Aortic Intervention, Interv...
2013 health and medical budget is set at 1.93 trillion won
A total of 1.93 trillion won was set aside for this year’s budget of health and medical sector, up 22.1 percent from last year, the Ministry of Health and Welfare said yesterday.
The proposed budget allocated by th...
Boryung names new executives in shake-upBoryung Pharm yesterday named Choi Tae-hong as its president in a management reshuffle.
After graduating from Seoul National University with a degree in medicine, Choi, 56, b...
|
Kolmar Korea in tie-up with Pharmascience
Kolmar Korea, one of the nation’s innovative pharmaceutical firms, said Saturday it has signed an agreement with Pharmascience Inc. to establish Pharmascience Korea, a joint venture firm here in 2014.
Pharmascience...
Concerns growing over another price cuts in blockbuster drugs
The government’s plan to re-price the drugs that exceed their initial sales forecasts in the first half of next year has triggered concerns from the industry.
Under the current regulation, drug manufacturers and th...
Pradaxa to be covered by health insuranceThe Ministry of Health and Welfare said Thursday it plans to expand the coverage of health insurance for Pradaxa (dabigatran etexilate) from January 1.
The insurance prices f...
|
Whanin, Sandoz Korea to co-market three antidepressants
Whanin Pharm and Sandoz Korea on Wednesday announced that the two companies have signed an agreement to co-market three antidepressants (escitalopram, paroxetine and sertraline) from next year in Korea.
Underscorin...
Hanmi wins Korean patent for antineoplastic composition
Hanmi Pharm said Thursday that it acquired a Korean patent for a composition that may safely extend the expiration date of a target anticancer drug up to a couple of years.
The title of this invention is “Pharmaceu...
Some drug firms will be at risk of losing “innovative pharmaceutical firm” status
The Ministry of Health and Welfare said Wednesday that it will cancel the title of innovative pharmaceutical firms that have been caught providing illicit kickbacks or rebate to hospitals in return for purchasing its ...
